MEXICO CITY, Jan. 9 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), a leading Mexican over-the-counter ("OTC") pharmaceuticals and personal care products company announced that on January 12, 2009 it will initiate the operation of a stock repurchase fund according to the terms approved by the Company's Board of Directors for an amount of up to Ps. 100 million pesos.
Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico with international presence. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.
Genomma Lab performed its Initial Public Offering in June, 2008, through a combined offering (mainly primary) and is listed on the Mexican Stock Exchange under the ticker symbol "LAB.B" (Bloomberg: labb.mx).
Web Site: www.genommalab.com
|SOURCE Genomma Lab Internacional, S.A.B. de C.V.|
Copyright©2009 PR Newswire.
All rights reserved